Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Human Genome Sciences discloses novel approach to malignancy

Oct. 4, 1996

Anticancer MMP inhibitor enters clinical trials

Oct. 4, 1996

Takeda's anticancer drug pipeline reviewed

Sep. 27, 1996

Promising preclinical and clinical results for Genta's lead antisense compound

Sep. 27, 1996

Clinical benefits of p53 gene therapy

Sep. 27, 1996

Antisense compound displays activity in animal models of human cancer

Sep. 27, 1996

Clinical trial of gene therapy for malignant brain tumors

Sep. 27, 1996

ET-743 product overview and development update

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Antitumor lipid peroxidation inhibitor from Kirin Brewery

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026